70 participants
Ablation in Combination With Lenvatinib and Anti-PD-1 Antibodies
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-07-24
- Start Date:
- 2024-01-01
- Completion:
- 2024-11-01
Conditions
- Hepatocellular Carcinoma
Interventions
- DRUG
- PROCEDURE
No Results Yet